Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.
Does Your eCOA Reduce Clinical Trial Risk?
YPrime announces a new report unveiling the top challenges that clinical trial executives face when implementing eCOA, and what to look for when evaluating new solutions.
2024 Annual Life Sciences Financial Planning & Accounting Report
2023 Clinical Trials Accounting & Reporting Benchmark Survey
Digital biomarkers show early clinical validity and provide greater confidence in Movement Disorder clinical trials
Digital biomarkers, smartphones, and wearables are transforming clinical trials by revolutionizing remote data collection and providing insights into treatment efficacy. Learn more about these exploratory endpoints and how they provide greater confidence in a clinical trial.
Five Key Benefits of Digital Biomarkers
Explore the five key advantages that underscore the significance of digital measurements in the context of clinical trials
2023 Clinical Research Industry Salary & Employee Satisfaction Survey Report